Navigation Links
Avandia Heart Risks Buried by Drug Company: Report
Date:7/13/2010

By Amanda Gardner
HealthDay Reporter

TUESDAY, July 13 (HealthDay News) -- The pharmacy company that makes Avandia knew more than a decade ago that the blockbuster diabetes drug caused an increased risk of heart problems but covered up the information, according to a report published Tuesday in The New York Times.

In a 1999 trial pitting Avandia against its competitor, Actos, the drug company, then known as SmithKline Beecham, found that Avandia posed a heart risk, the newspaper reported.

The Times report, based on internal company documents it obtained, said that the company did not post results of its drug trial findings on its Web site or submit them to federal regulators.

According to a March 29, 2001, e-mail message the Times obtained, Dr. Martin I. Freed, a company executive, wrote about the study results: "This was done for the U.S. business, way under the radar. Per Sr. Mgmt request, these data should not see the light of day to anyone outside of GSK." GlaxoSmith Kline is the corporate successor to SmithKline.

The safety of Avandia (rosiglitazone) comes under U.S. government scrutiny starting Tuesday, as an advisory panel of experts begins two days of hearings.

The new information released by the Times comes after new doubts surfaced last week on a key trial that helped keep Avandia on the market.

Last Friday, a medical reviewer for the U.S. Food and Drug Administration posted remarks on the agency's Web site suggesting that GlaxoSmithKline's "mishandling" of trial results may have masked some cardiovascular effects of Avandia.

The official's posting was part of a safety reassessment package prepared for the FDA's advisory panel meeting.

At issue in the review posting were the results of the landmark RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes) trial, which was done by Glaxo at the FDA's r
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Diabetes Drugs Avandia, Actos Tied to Fractures in Women
2. Remove Diabetes Drug Avandia From Market: FDA Reports
3. Remove Diabetes Drug Avandia From Market: FDA Documents
4. FDA Says It Hasnt Decided Whether to Pull Diabetes Drug Avandia Off the Market
5. FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market
6. Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia
7. Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
8. Latest Study on Diabetes Drug Avandia Finds No Heart Risks
9. FDA Reviewer Questions Results of Key Avandia Trial
10. ICU Patients at Risk for Rare Heart Rhythm Problem
11. Cook With Love This Valentines Day With Heart-Smart Recipes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avandia Heart Risks Buried by Drug Company: Report
(Date:8/1/2015)... NY (PRWEB) , ... August 01, 2015 , ... Calvary ... scroll currently housed at their Bronx campus. The goal is to bring this Torah ... again be used in Jewish rituals and religious services. , Scroll No. 515, ...
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the network ... their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been ... companies have agreed to join their missions of purpose together to change the course ...
(Date:8/1/2015)... ... 01, 2015 , ... On Tuesday, July 28th, Symantec released a security industry ... been behind the attack on Anthem Inc. which resulted in one of the largest ... attacks and spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO ...
(Date:8/1/2015)... ... ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair Care, has announced her ... to kick off the campaign for healing and Well-Being. , BeverlyD has helped women ... of raw, organic hair care products, as well as her book, Hair Now!— The ...
(Date:8/1/2015)... , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the ... of the Appalachian Trail by stepping off Springer Mountain and heading north. Since ... July 26th Phil reached Connecticut and was greeted by friends and family. He visited ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... menstrual pain, migraines and acne may be other ... Dec. 22 (HealthDay News) -- Along with preventing ... as severe menstrual pain and heavy menstrual bleeding, ... the American College of Obstetricians and Gynecologists. , ...
... (December 22, 2009) A new study published in the ... of Surgeons shows that a volunteer program providing low-risk ... to patients in need. However, the study authors do caution ... with the medically uninsured. While Congress and the ...
... , RIVERWOODS, Ill., ... has updated three of its Special Tax Briefings on the ... a Wolters Kluwer business and a leading provider of tax, accounting and ... coverage visit CCH Tax Legislation Coverage , or: , for ...
... , Appointments may be made at H1N1inPA.com or by phone , ... H1N1 flu vaccination clinics at 33 locations across Pennsylvania on Jan. ... urged to make an appointment to attend. , "We are ... it," said Health Secretary Everette James. "Even though flu activity is ...
... CRP may be due to other factors , TUESDAY, ... a protein that indicates tissue inflammation in the body to ... disease. , But the association may be the result of ... rather than the protein itself, researchers said. , The molecule, ...
... Craig Harrison found out he would be the first patient ... performed at UT Southwestern Medical Center, he wasn,t nervous at ... was actually excited about it," Mr. Harrison said. "I had ... Michael DiMaio, associate professor of cardiovascular and thoracic surgery at ...
Cached Medicine News:Health News:The 'Pill' Offers Benefits Beyond Birth Control 2Health News:Volunteer program provides quality low-risk operative care to patients in need 2Health News:Volunteer program provides quality low-risk operative care to patients in need 3Health News:CCH Updates Briefings on Tax Provisions of Estate Tax, Tax Extender, Health Care Reform Bills 2Health News:Department of Health to Offer H1N1 Vaccine Clinics for All Pennsylvanians 2Health News:Fort Worth patient first in North Texas to undergo robot-assisted surgery for removal of lung tumor 2
(Date:7/30/2015)... PARK, N.J. , July 30, 2015  Unichem ... voluntarily recalling one lot of Hydrochlorothiazide tablets 25 mg ... been initiated as a precautionary measure due to the ... of the product. The risk associated ... Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel,s ...
(Date:7/30/2015)... N.J., July 30, 2015 PTC Therapeutics, Inc. ... and reported financial results for the second quarter ending ... on many fronts across the organization.  We are excited ... muscular dystrophy clinical trial ever conducted with topline results ... Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is ...
(Date:7/30/2015)... 30, 2015  Cleveland Clinic President Wael Barsoum ... last month that industry is compelled to adopt declining ... the efficiencies—and develop the transformational innovations -- required to ... were preceded by Doug Kohrs , past President ... who stressed that industry must add "episode of care," ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... progression reduced by 40 percent compared,to delayed treatment ... Pharma AG,Germany, announced today new data, which show ... with a first event suggestive of multiple sclerosis ... as measured by the Expanded Disability Status Scale,(EDSS) ...
... in Primate Study, CHICAGO, May 02, 2007 /PRNewswire-FirstCall/ ... its novel respiratory,antibiotic, Cethromycin, was shown to be ... reached from a,primate study where a 30-day course ... dose of inhaled anthrax as compared to,the standard ...
Cached Medicine Technology:Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 2Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 3Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 4Cethromycin Shown Effective Against Anthrax in Study 2Cethromycin Shown Effective Against Anthrax in Study 3Cethromycin Shown Effective Against Anthrax in Study 4
... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
... Durable ergonomic chairs with concave seats and ... options like seats, backrests, armrests, and casters ... for top performance in a variety of ... static control, health care and office. • ...
... ergonomic chairs with concave seats and large ... like seats, backrests, armrests, and casters and ... top performance in a variety of environments ... control, health care and office. • With ...
... ergonomic chairs with concave seats and large ... like seats, backrests, armrests, and casters and ... top performance in a variety of environments ... control, health care and office. • With ...
Medicine Products: